Pulmonary hypertension in chronic obstructive pulmonary disease: current theories of pathogenesis and their implications for treatment.
about
Pulmonary hypertension survival effects and treatment options in cystic fibrosisAnimal models of chronic obstructive pulmonary diseaseLong-term effects of acupuncture treatment on airway smooth muscle in a rat model of smoke-induced chronic obstructive pulmonary disease.Induction of vascular remodeling in the lung by chronic house dust mite exposure.Exhaled and arterial levels of endothelin-1 are increased and correlate with pulmonary systolic pressure in COPD with pulmonary hypertensionCanadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease - 2007 updateRole of chymase in cigarette smoke-induced pulmonary artery remodeling and pulmonary hypertension in hamsters.Plasma C-reactive protein and endothelin-1 level in patients with chronic obstructive pulmonary disease and pulmonary hypertension.Cigarette smoke exposure up-regulates endothelin receptor B in human pulmonary artery endothelial cells: molecular and functional consequencesEffects of basic fibroblast growth factor and cyclin D1 on cigarette smoke-induced pulmonary vascular remodeling in rats.Cigarette Smoke-Induced Emphysema and Pulmonary Hypertension Can Be Prevented by Phosphodiesterase 4 and 5 Inhibition in MiceIL-18 induces emphysema and airway and vascular remodeling via IFN-γ, IL-17A, and IL-13Update in chronic obstructive pulmonary disease 2005.Remodeling of extra-bronchial lung vasculature following allergic airway inflammation.SENP‑1 enhances hypoxia‑induced proliferation of rat pulmonary artery smooth muscle cells by regulating hypoxia‑inducible factor‑1α.Tobacco smoke induced COPD/emphysema in the animal model-are we all on the same page?Phenotypes of chronic obstructive pulmonary disease.Role of IL-18 in second-hand smoke-induced emphysemaMechanisms of cigarette smoke-induced COPD: insights from animal models.Exercise intolerance and systemic manifestations of pulmonary emphysema in a mouse model.Association of chronic obstructive pulmonary disease and obstructive sleep apnea consequencesVascular endothelial growth factor of the lung: friend or foeTargeted treatment in COPD: a multi-system approach for a multi-system disease.The immediate effect of soft tissue manual therapy intervention on lung function in severe chronic obstructive pulmonary disease.The Saudi Guidelines for the Diagnosis and Management of COPD.Effect of Smoking on Metalloproteinases (MMPs) Activity in Patients with Acute Myocardial Infarction (AMI).Role of phosphatase and tensin homolog in hypoxic pulmonary vasoconstriction.Decrease in Small Pulmonary Vessels on Chest Computed Tomography in Light Smokers Without COPD: An Early Change, but Correlated with Smoking Index.Quantification of nonuniform distribution of hemi-lung perfusion in chronic obstructive pulmonary disease.Nebulization of the acidified sodium nitrite formulation attenuates acute hypoxic pulmonary vasoconstriction.Cigarette smoke extract stimulates rat pulmonary artery smooth muscle cell proliferation via PKC-PDGFB signaling.Mitochondrial ROS-K+ channel signaling pathway regulated secretion of human pulmonary artery endothelial cells.Contribution of CXCR4(+)/PDGFRbeta(+) progenitor cells in hypoxic alveolar arterioles muscularization: role of myocardin.Smoking: Is it a risk factor for pulmonary vascular diseases?Comparison and evaluation of two different methods to establish the cigarette smoke exposure mouse model of COPD.ERK1/2 promotes cigarette smoke-induced rat pulmonary artery smooth muscle cells proliferation and pulmonary vascular remodeling via up-regulating cycline1 expression.Statin reverses smoke-induced pulmonary hypertension and prevents emphysema but not airway remodeling.Short-term exposure to cigarette smoke induces endothelial dysfunction in small intrapulmonary arteries: analysis using guinea pig precision cut lung slices.Small interfering RNA against ERK1/2 attenuates cigarette smoke-induced pulmonary vascular remodeling.Implication of PDGF signaling in cigarette smoke-induced pulmonary arterial hypertension in rat.
P2860
Q26825432-CD744A92-8127-41C1-91EB-FC952BC19038Q28385105-5D5C2295-61C1-4DBD-93E4-8636515EAFF8Q30378871-6656E839-6908-49B9-A5FA-12B3FB61954FQ33322072-9B0E0BA4-F960-4F15-9522-80DBD6CF5A17Q33372442-32FE255F-0423-4739-B4DE-3E655A2EC461Q33591899-E6BA6AF0-BD5B-4F9D-89B6-AB7387A3677DQ33784445-8DC1F863-17AB-4F97-8457-E64EDD4A83B1Q34159759-CA6BBE08-1553-4191-B170-D446E922EB2BQ34442358-F2209CCA-66D6-4C1A-9B36-29DA39B05679Q34585197-A00D6115-E5D0-4637-9A68-1BD2FEDCC93EQ35658509-F553366C-F70A-4EB7-A2E5-12776F53F51FQ36026286-1BC5DC63-684D-4BA2-B395-7E5CFE745DC3Q36470462-661A8D50-EF31-400D-A65B-08B9928DAF26Q36478639-E7037FEF-6F12-485E-90D4-3EA3745DFA55Q36722154-940D0EC7-1F13-48A6-A44C-A8B1B5DD6E4AQ36844617-1B23ACA6-ED86-40B4-9AAF-3F4D5FCA9AFCQ37008634-FACC07A3-142E-4C27-84B9-FC1A26816499Q37056441-C8153849-16A2-4CF7-B694-1ADA06A2A195Q37068538-5914DAD4-0759-46DD-98A8-18AAA59CAC20Q37102193-D5595B46-1EF5-4641-BF32-47AE455ED449Q37115862-F00A772F-0B2A-41F0-8CE7-AE53C7213D39Q37158665-00F9E446-5AEF-4D8E-8C59-B01061CB0214Q37340178-07914773-926E-40E2-A507-8380E3E60281Q37669155-AA1F3133-1D92-46D2-9522-012CB74A2851Q37733309-177ADB87-DA9B-403A-9926-6C51740FC795Q38587974-C0796D34-387D-4D13-84CB-FB440C460E2CQ38826623-5F9113DC-52F5-46A7-B808-CD0C365CB258Q39146133-AB43A70F-607B-4A9A-B181-0377F31D37AFQ40336049-FDCFBD9E-3CCD-4D35-9613-17D00391C489Q41875328-1AB88F34-9974-4879-8A26-B4B59742E8B9Q41952153-1DF424AC-33E4-4C20-94F3-8B7AA5979917Q42716225-0F645572-2BB4-4853-9F99-EDB906278B86Q42826636-3326E157-9012-43B7-A8FB-59428B41C3F7Q42923058-3F1840CE-88E6-4F47-8994-AA8BC12DBBAEQ43598338-E34EE652-0CCB-495C-9D20-627C3DCDE408Q45354269-651A2AF0-1B37-4761-A142-17F787B08FA6Q46227006-7BA8A551-7093-413D-B0B6-0543EEB22BB6Q46690166-C7362C3F-82B4-46A6-B54F-500D7E3A166FQ47104024-075DCEB6-5DD6-4DF8-B7B7-D2FFAE22073DQ47434568-8F221542-16FD-4026-998A-C9598FDE177A
P2860
Pulmonary hypertension in chronic obstructive pulmonary disease: current theories of pathogenesis and their implications for treatment.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Pulmonary hypertension in chro ...... ir implications for treatment.
@ast
Pulmonary hypertension in chro ...... ir implications for treatment.
@en
type
label
Pulmonary hypertension in chro ...... ir implications for treatment.
@ast
Pulmonary hypertension in chro ...... ir implications for treatment.
@en
prefLabel
Pulmonary hypertension in chro ...... ir implications for treatment.
@ast
Pulmonary hypertension in chro ...... ir implications for treatment.
@en
P2093
P2860
P356
P1433
P1476
Pulmonary hypertension in chro ...... ir implications for treatment.
@en
P2093
P2860
P304
P356
10.1136/THX.2005.042994
P407
P577
2005-07-01T00:00:00Z